Loading...
OTCM
KLYG
Market cap1mUSD
Dec 05, Last price  
0.14USD
1D
13.02%
1Q
97.14%
IPO
-13.75%
Name

Kelyniam Global Inc

Chart & Performance

D1W1MN
OTCM:KLYG chart
P/E
P/S
0.52
EPS
Div Yield, %
Shrs. gr., 5y
14.08%
Rev. gr., 5y
8.80%
Revenues
3m
+24.55%
69,25046,5671,857,5161,748,4191,519,6291,526,1351,848,1042,123,6992,183,1252,512,1012,664,4343,017,5992,672,3573,328,384
Net income
-920k
L+321.20%
-114,186-182,70114,936-4,772-39,963-13,512-72,538-15,304-357,953141,075201,741-97,560-218,471-920,206
CFO
104k
P
28,357331056,30536,70911,797141,45015,002-239,294202,025124,297-31,753-95,773103,581

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers. The company develops, manufactures, and distributes custom cranial and craniofacial fixation screws for patients requiring the reconstruction of cranial and facial structures. It serves health systems, hospitals, sales representative, and surgeons, payors, and patients. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007. The company was incorporated in 2005 and is based in Collinsville, Connecticut.
IPO date
Apr 03, 2008
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT